AbstractDisorders of lipid metabolism affect several tissues, including skeletal and cardiac muscle tissues. Lipid myopathies (LM) are rare multi-systemic diseases, which most often are due to genetic defects. Clinically, LM can have acute or chronic clinical presentation. Disease onset can occur in all ages, from early stages of life to late-adult onset, showing with a wide spectrum of clinical symptoms. Muscular involvement can be fluctuant or stable and can manifest as fatigue, exercise intolerance and muscular weakness. Muscular atrophy is rarely present. Acute muscular exacerbations, resulting in rhabdomyolysis crisis are triggered by several factors. Several classifications of lipid myopathies have been proposed, based on clinical involvement, biochemical defect or histopathological findings. Herein, we propose a full revision of all the main clinical entities of lipid metabolism disorders with a muscle involvement, also including some those disorders of fatty acid oxidation (FAO) with muscular symptoms not included among previous lipid myopathies classifications. View Full-Text
Share & Cite This Article
Pennisi, E.M.; Garibaldi, M.; Antonini, G. Lipid Myopathies. J. Clin. Med. 2018, 7, 472.
Pennisi EM, Garibaldi M, Antonini G. Lipid Myopathies. Journal of Clinical Medicine. 2018; 7(12):472.Chicago/Turabian Style
Pennisi, Elena M.; Garibaldi, Matteo; Antonini, Giovanni. 2018. "Lipid Myopathies." J. Clin. Med. 7, no. 12: 472.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.